Dr. Amalia Soenens is a Product Manager at EditCo, where she combines her scientific background with a passion for customer-focused innovation. After completing her PhD in Microbiology, she transitioned from the lab bench into customer-centric roles across biotech startups, working at the intersection of cutting-edge science and commercial strategy. Her career has spanned private equity-backed startups in instrumentation, reagents, and services, where she has led both e-commerce-driven product lines and sales-driven service offerings. Amalia is especially passionate about developing solutions that meet real customer needs- integrating scientific understanding, advanced technologies, and market insight to create impactful, innovation-driven products.
Wednesday, 18 June 2025
Time |
Session |
|
08:30
09:15
|
-
Introduction
-
Unveiling SURF2’sRole in Nucleolar Stress and Its Potential as a Therapeutic Target
-
AI-driven identification and validation of novel synthetic lethal gene pairs
-
Leveraging an advanced CRISPR platform to streamline oncology breakthroughs
Auditorium 2
|